Integral Diagnostics Limited (IDX.AX)
AUD 2.9
(-2.68%)
AUD 2.9
(-2.68%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 469.69 Million | 440.09 Million | 358.73 Million | 348.8 Million | 274.08 Million | 232.39 Million |
| Cost of Revenue | 365.89 Million | 342.33 Million | 274.89 Million | 256.61 Million | 202.01 Million | 141.41 Million |
| Gross Profit | 103.8 Million | 97.76 Million | 83.84 Million | 92.19 Million | 72.06 Million | 90.97 Million |
| Operating Expenses | 61.88 Million | 57.62 Million | 45.39 Million | 44.31 Million | 33.65 Million | 54.73 Million |
| Selling, General and Administrative Expenses | 61.88 Million | 58.28 Million | 47.58 Million | 44.31 Million | 33.65 Million | 23.52 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 140.97 Million | 663 Thousand | 2.19 Million | -152 Thousand | -3.62 Million | 73 Thousand |
| Cost and Expenses | 469.69 Million | 399.96 Million | 320.29 Million | 300.93 Million | 235.67 Million | 196.15 Million |
| Operating Income | 5.36 Million | 40.13 Million | 38.44 Million | 47.87 Million | 38.4 Million | 37.87 Million |
| Interest Expense | 22.31 Million | 18.29 Million | 10.48 Million | 8.81 Million | 8.55 Million | 6.19 Million |
| Income Tax Expense | 3.56 Million | 5.59 Million | 7.95 Million | 13.95 Million | 12.22 Million | 9.63 Million |
| Earnings before Tax | -57.07 Million | 30.96 Million | 22.71 Million | 45.2 Million | 35.26 Million | 30.61 Million |
| Net Income | -60.69 Million | 25.04 Million | 14.6 Million | 31.26 Million | 23.03 Million | 20.98 Million |
| Earnings Per Share Basic | -0.26 | 0.11 | 0.07 | 0.16 | 0.12 | 0.10 |
| Earnings Per Share Diluted | -0.26 | 0.11 | 0.07 | 0.15 | 0.12 | 0.10 |
| Weighted Average Shares Outstanding | 233.49 Million | 232.71 Million | 209.37 Million | 201.39 Million | 201.39 Million | 201.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 233.49 Million | 235.79 Million | 211.86 Million | 201.39 Million | 201.39 Million | 201.39 Million |
| Gross Margin | 0.22 | 0.22 | 0.23 | 0.26 | 0.26 | 0.39 |
| EBIT Margin | 0.03 | 0.19 | 0.21 | 0.24 | 0.23 | 0.22 |
| Profit Margin | -0.13 | 0.06 | 0.04 | 0.09 | 0.08 | 0.09 |
| EBITDA | 12.33 Million | 92.74 Million | 69.9 Million | 88.93 Million | 69.49 Million | 50.32 Million |
| Earnings Before Tax Margin | 0.01 | 0.09 | 0.11 | 0.14 | 0.14 | 0.16 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 469.69 Million | 238.44 Million | 231.25 Million | 224.39 Million | 440.09 Million | 215.7 Million |
| Cost of Revenue | 365.89 Million | 185.55 Million | 180.1 Million | 173.84 Million | 342.33 Million | 168.49 Million |
| Gross Profit | 103.8 Million | 52.88 Million | 51.15 Million | 50.55 Million | 97.76 Million | 47.2 Million |
| Operating Expenses | 61.88 Million | 30.14 Million | 30.86 Million | 27.89 Million | 57.62 Million | 29.3 Million |
| Selling, General and Administrative Expenses | - | 30.62 Million | 31.24 Million | 28.75 Million | - | 29.54 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -2.91 Million | 482 Thousand | 379 Thousand | 867 Thousand | 663 Thousand | 244 Thousand |
| Cost and Expenses | 427.78 Million | 215.7 Million | 210.96 Million | 201.73 Million | 399.96 Million | 197.79 Million |
| Operating Income | 41.91 Million | 22.74 Million | 20.28 Million | 22.66 Million | 40.13 Million | 17.9 Million |
| Interest Expense | 17 Million | 11.13 Million | 11.41 Million | 9.8 Million | 18.29 Million | 8.56 Million |
| Income Tax Expense | 3.56 Million | 2.57 Million | 989 Thousand | 3.24 Million | 5.59 Million | 2.34 Million |
| Earnings before Tax | -57.07 Million | 8.63 Million | -65.7 Million | 12.26 Million | 30.96 Million | 18.69 Million |
| Net Income | -60.69 Million | 6.05 Million | -66.75 Million | 8.9 Million | 25.04 Million | 16.13 Million |
| Earnings Per Share Basic | - | 0.03 | -0.29 | 0.04 | - | 0.07 |
| Earnings Per Share Diluted | - | 0.03 | -0.29 | 0.04 | - | 0.07 |
| Weighted Average Shares Outstanding | 233.49 Million | 233.91 Million | 233.24 Million | 233.02 Million | 232.71 Million | 232.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 233.49 Million | 233.91 Million | 233.24 Million | 236.19 Million | 235.79 Million | 235.57 Million |
| Gross Margin | 0.22 | 0.22 | 0.22 | 0.23 | 0.22 | 0.22 |
| EBIT Margin | - | 0.20 | 0.19 | 0.20 | - | 0.18 |
| Profit Margin | -0.13 | 0.03 | -0.29 | 0.04 | 0.06 | 0.07 |
| EBITDA | - | 46.75 Million | 43.13 Million | 44.78 Million | - | 39.27 Million |
| Earnings Before Tax Margin | 0.09 | 0.10 | 0.09 | 0.10 | 0.09 | 0.08 |
GLDS
PHRZF
VIVE
ALGS
FORM
UEL